Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. hVIVO Share Price
  4. hVIVO Share Regulatory News
  5. Open Orphan

Pin to quick pickshVIVO Regulatory News (HVO)

hVIVO Information

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
8.85    0.45 (5.36%)
Bid:
8.70
Ask:
9.00
Spread: 0.30 (3.448%)
Market Cap: £60.92m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

Open Orphan

15 Jan 2020 17:30

RNS Number : 9383Z
FTSE Russell
15 January 2020
 

 

 

 

 

Open Orphan (UK): Merger with Hvivo (UK)Changes in FTSE UK Index Series

15 January 2020

Subject to the completion of the merger between Open Orphan (UK, constituent) and Hvivo (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

20 January 2020

 

* The number of shares is based on the merger terms of 2.47 new Open Orphan shares for every Hvivo share held.

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSSFWFIIESSEIF
123456789
Date   Source Headline
21st Jun 20187:00 amRNSNotification of Major Interest in Shares
20th Jun 20182:00 pmRNSNotification of Major Interest in Shares
20th Jun 201811:05 amRNSSecond Price Monitoring Extn
20th Jun 201811:00 amRNSPrice Monitoring Extension
20th Jun 20187:00 amRNSNotification of Major Interest in Shares
19th Jun 20189:05 amRNSSecond Price Monitoring Extn
19th Jun 20189:00 amRNSPrice Monitoring Extension
18th Jun 20187:00 amRNSPositive Results for Phase IIb FLU-v Field Study
23rd May 201812:30 pmRNSResult of AGM
27th Apr 20182:00 pmRNS2017 Annual Report and Financial Statements
19th Apr 20187:01 amRNSAudited 2017 Preliminary Results
19th Apr 20187:00 amRNSChief Executive Officer Steps Down
10th Apr 20187:00 amRNSStatement regarding share price
6th Apr 20187:00 amRNSNotice of Preliminary Results
5th Apr 201812:00 pmRNSDirectors' Dealings
26th Mar 20187:00 amRNSInitial results from a Phase IIb study of FLU-v
16th Jan 20187:00 amRNSAward of Share Options
9th Jan 20187:00 amRNSDirectors' Dealings
21st Dec 20177:00 amRNSAward of Share Options
14th Dec 20172:00 pmRNSDirector's Dealings
30th Oct 20177:00 amRNSDirectorate Change
5th Oct 20177:00 amRNSDirectors' Dealings
21st Sep 20177:00 amRNSHalf-year Report
10th Jul 20177:00 amRNSDirectors' Dealings
20th Jun 20177:00 amRNSBoard Change
24th May 20172:00 pmRNSResult of Annual General Meeting
18th May 20177:00 amRNSAward of Deferred Bonus Share Options
28th Apr 20172:00 pmRNS2016 Annual Report and Financial Statements
20th Apr 20177:00 amRNSAudited 2016 Preliminary Results
13th Apr 20177:00 amRNSTrading Update
5th Apr 20177:00 amRNSDirectors' Dealings
21st Feb 20174:30 pmRNSInitiation of a Phase I clinical trial with AGS-v
9th Feb 20177:00 amRNSData from PrEP Biopharm's Ph. IIa clinical studies
5th Jan 20177:00 amRNSDirectors' Dealings
30th Dec 20167:00 amRNSChange of auditor
27th Oct 20167:00 amRNSNotification of Major Interest in Shares
12th Oct 20167:00 amRNSDirectors' Dealings
23rd Sep 20167:00 amRNSExercise of Share Options
22nd Sep 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSTrading Update
8th Sep 20167:00 amRNSNotification of Major Interest in Shares
2nd Sep 20167:00 amRNShVIVO Landmark Asthma Study Underway
4th Aug 20167:00 amRNSDirectors' Dealings
12th Jul 201612:45 pmRNSNotification of Major Interest in Shares
14th Jun 201612:00 pmRNSFavourable results for PrEP Biopharm's Flu Study
24th May 20167:00 amRNSDavid Norwood Lock-in Deed
23rd May 201612:00 pmRNSResult of AGM
28th Apr 20162:05 pmRNS2015 Annual Report and Financial Statements
27th Apr 20167:00 amRNSNotification of Major Interest in Shares
25th Apr 20167:00 amRNSInitial results for PrEP Biopharm's Flu study
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IOG
IOG.L
LSE
0.00%
BRGE
BlackRock Greater Europe Investment Trust
LSE
-0.52%
TED
TED.L
LSE
0.00%
VLX
Volex
LSE
-4.70%
BRSC
BlackRock Smaller Companies Trust PLC
LSE
-1.22%
Trending
NANO
Nanoco
LSE
-10.69%
RRR
Red Rock Resources
LSE
-2.00%
IMM
Immupharma
LSE
-2.26%
ALRT
Defence Holdings
LSE
19.05%
0RIP
Bet-at-home.com
LSE
-0.73%